Basics Standard BioTools Inc. IPO Date: March 1, 2011 Sector: Healthcare Industry: Diagnostics and Research Market Cap: $496.59M Activated in VL: True Average Daily Range Avg Daily Range: $0.07 | 3.54% Avg Daily Range (30 D): $0.03 | 2.13% Avg Daily Range (90 D): $0.04 | 3.26% Institutional Daily Volume Avg Daily Volume: .27M Avg Daily Volume (30 D): 1.05M Avg Daily Volume (90 D): 1.38M Trade Size Avg Trade Size (Sh.): 188 Avg Trade Size (Sh.) (30 D): 236 Avg Trade Size (Sh.) (90 D): 231 Institutional Trades Total Inst.Trades: 117 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $.5M Avg Inst. Trade (90 D): $1.61M Avg Inst. Trade Volume: .95M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.01M Avg Closing Trade (30 D): $.5M Avg Closing Trade (90 D): $1.02M Avg Closing Volume: 1.61M     News Jul 21, 2025 @ 11:00 AM Standard BioTools Schedules Second Quarter Earning... Source: Marissa Bychir Apr 22, 2025 @ 11:00 AM Standard BioTools Schedules First Quarter Earnings... Source: N/A Jan 13, 2025 @ 12:00 PM Standard BioTools Announces Preliminary Fourth Qua... Source: N/A Dec 19, 2024 @ 1:00 PM Standard BioTools to Present at the 43rd Annual J.... Source: N/A Nov 7, 2024 @ 1:00 PM Standard BioTools Appoints Alex Kim as Chief Finan... Source: Standard Biotools Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.31 $-.09 $-.07 Diluted EPS $-.31 $-.09 $-.07 Revenue $ 133.67M $ 21.76M $ 40.8M Gross Profit $ 66.84M $ 10.63M $ 19.74M Net Income / Loss $ -120.5M $ -33.46M $ -26.03M Operating Income / Loss $ -117.2M $ -25.7M $ -32.97M Cost of Revenue $ 66.83M $ 11.13M $ 21.05M Net Cash Flow $ -109.9M $ 7.73M $ -15.35M PE Ratio